OmniComm Systems, Inc. engages in providing software solutions in the field of sciences. It supports customers through innovative technologies in management of risks, regulatory compliance, and clinical operations in the field of pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers. Its products include 21 CFR Part 11 designed to offer clinical trial sponsors the ability to conduct clinical trials under multiple platforms. The company was founded by Randall G. Smith on November 19, 1996 and is headquartered in Fort Lauderdale, FL.
Company profile
Ticker
OMCM
Exchange
Website
CEO
Stephen Eric Johnson
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Coral Development Corp
SEC CIK
Corporate docs
IRS number
113349762
OMCM stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
18 Sep 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Sep 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Sep 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Sep 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Sep 19
8-K
Anju Completes Merger With OmniComm Systems
18 Sep 19
DEFM14C
Information related to merger
29 Aug 19
10-Q
2019 Q2
Quarterly report
14 Aug 19
PREM14C
Preliminary information related to merger
14 Aug 19
8-K
Entry into a Material Definitive Agreement
16 Jul 19
Latest ownership filings
SC 13D/A
Beneficial ownership report (amended)
20 Sep 19
4
CORNELIS F WIT
20 Sep 19
4
Gary A Shangold
19 Sep 19
4
ROBERT C SCHWEITZER
19 Sep 19
4
Adam F. Cohen
19 Sep 19
4
Stephen Eric Johnson
19 Sep 19
4
Thomas E Vickers
19 Sep 19
4
Keith L Howells
19 Sep 19
4
John D Fontenault
19 Sep 19
4
der Post Kuno D van
19 Sep 19